Last month we held our annual strategy day at SNIPR: talks, workshops and some teambuilding. A good day to step back, think ahead together and get a bit of fresh energy for the months to come. Thanks to everyone who made it happen!
We’re honoured to be recognised at the TechEU Equity Summit for our contribution to the EU biotech ecosystem. We receive this award as part of a broader community of companies working to make Europe more competitive, resilient, and to improve people’s lives. @EIB @NadiaCalvino
We'll be at GAMRIC, the Global AMR Innovators Conference, in Lisbon next week, 22–24 September. @ESCMID
📅 Tue 22 Sept, 16:45–18:15: @EricvdHelm on the SNIPR001 Phase 1 results
📅 Wed 23 Sept , 13:00–14:00: @groendahl joins the panel discussion
First patient enrolled in Phase 2 of our SNIPR001 trial. The study expands to 66 patients across ten sites, now including Memorial Sloan Kettering and Dana-Farber.
Read the full press release: static1.squarespace.com/stat…
#PRESS
🧬 We're hiring: Student Assistant, Preclinical Team
Are you early in a master's programme in biology, microbiology, biotechnology or a related field, looking for lab experience that actually counts?
📅 Deadline: 25 August 2026
Full description: sniprbiome.com/student-assis…
A peer-reviewed case report on the use of engineered CRISPR-phage therapy in a rare intracellular, multidrug-resistant Escherichia coli infection has been published today in Clinical Infectious Diseases (@IDSAInfo).
Details in the press release: sniprbiome.com/newsandpress/…
#PRESS
We're excited to have @wholelysedup, our Director of Phage Engineering, speaking at @VirusOfMicrobes 2026 about SNIPR001 in Prague this week.
Wednesday 8th July 2026 11:45 (15m)
Full program: vom2026.org/program
#VoM2026
We're hiring a Data Engineer at SNIPR in Copenhagen!
You'd build and maintain the pipelines, databases, and web applications (Python/Django, SQL, AWS) that connect our lab instruments, LIMS, and external data platforms.
Deadline: 2 August 2026
We are hiring a Director of Preclinical Testing to lead our In Vivo Pharmacology and In Vitro & Assays team here in Copenhagen.
Find the full job description and apply via the link below, apply by 17 June 2026. linkedin.com/jobs/view/44223…
Later this week, our @groendahl will open Day 2 of the @Jafral1 Phage Summit 2026 in Ljubljana as keynote speaker.
The talk will focus on how engineered phage-based therapies are moving from laboratory promise toward clinical reality.
We're hiring a Senior Project Manager with a solid project management toolbox and strong microbiology/bacteriology expertise to help drive key research projects forward in #AMR full details here: blackswansexist.com/job/seni…
SNIPR retweeted
Last month, @groendahl and I joined @CARB_X Investor Day in Munich ahead of @ESCMID Global. Always energizing to be among so many teams pushing #AMR innovation forward; from early discovery to clinical-stage programs.
Our CEO @groendahl had the privilege of joining this week's @AdamSmithHouse Dialogue on Market Solutions for #AMR Effectiveness, focused on generic antimicrobials as the load-bearing infrastructure of the AMR response. Thanks for convening such a thoughtful conversation!
This week we hosted the second dialogue in the Panmure House Dialogues programme: Market Solutions for Antimicrobial Effectiveness (AME).
This session focused on ‘Generic antimicrobials as the crucial load-bearing elements of AME infrastructure’ and brought together a diverse group of contributors spanning biotechnology, clinical practice, microbiology, economics, and investment.
Through a series of panel discussions, participants explored key themes including resilient supply, universal access, and aligned incentives. As global health systems continue to face evolving infectious threats, these conversations are both timely and essential. We are proud to continue Adam Smith’s legacy by convening experts from across sectors to tackle some of today’s most complex challenges.
Thank you to those listed below for sharing their expertise and shaping this discussion. We look forward to publishing the outcomes soon on our Panmure House Perspectives page: panmurehouse.org/perspective…
Dr Liz Tayler, Professor Mike Sharland, Nobuko Ichikawa, Dr David Jenkins, Dr Melisa Williams Higgins, Maria Souza, David McKinney, Dr Christine Årdal, Dr Ali Cameron, Professor Dominic Moran, Professor W. Brian Arthur, Dr Robert Kimbui, Matthew Ford, Ella Hashemi, Ian Ball, Dr Christian Gröndahl, Dr Henry Skinner, Dr. Alicia Demirjian, Professor Adam Dixon, Dr Lucy Naga
We're hiring a Laboratory Technician to join our Preclinical Testing team in Copenhagen: hands-on work with bacteria, phages, and CRISPR-based medicines. 1-year position, apply by May 3 linkedin.com/jobs/view/44035…
🌍 Four events, three cities, one mission for SNIPR. We're excited to be taking our science and story across Europe over the next several days. We'd love to connect. 👋
#CRISPRMED26 #ESCMIDGlobal2026 #CRISPR @CARB_X #SPRIND @ESCMID @SPRIND
We were excited to welcome the production company Nordic Made Film earlier this week to film at SNIPR and interview our CEO @groendahl
The visit is part of a new documentary series, The Microbes That Save Us, highlighting how microbes and cutting-edge biotechnology.
We're at the 8th Annual Bacteriophage Summit in London this week! Tomorrow, Jonas Hink will take the stage to talk about advancing engineered phages toward clinical reality.
📅 Wednesday, 25 March | 4:00 PM
Today, we're excited to announce the publication of final Phase 1 results for SNIPR001, our CRISPR therapeutic designed to precisely reduce E. coli in the gut — including multi-drug resistant strains — while preserving healthy gut bacteria.
🔗 Read the paper in The Lancet Microbe: thelancet.com/journals/lanmi…
🔗 Full press release: globenewswire.com/news-relea…
We thank @CARB_X for supporting this work.
We’re excited to share real-world lessons from building and translating CRISPR-based antimicrobials - what’s worked, what hasn’t, and what it takes to move from promise to patient impact at the 10th @AMR_Conference . Come meet @EricvdHelm in Basel.













